会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • A METHOD OF IDENTIFYING A NEONATE AT RISK OF HAVING OR DEVELOPING HYPOXIC-ISCHAEMIC ENCEPHALOPATHY (HIE)
    • 鉴别患有或发展为高血压性心律失常(HIE)的风险的新生儿的方法
    • US20160348175A1
    • 2016-12-01
    • US15112036
    • 2015-01-16
    • UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
    • Deirdre MurrayAnn Marie LooneyGeraldine BoylanJohn Cryan
    • C12Q1/68A61F7/00
    • C12Q1/6883A61F7/00C12Q2600/178
    • A method for screening a distressed neonate for risk of having or developing HIE comprises the steps of assaying a biological sample obtained from the distressed neonate, the mother of the neonate, or from the umbilical cord or placenta, for an abundance of miR-374a in the sample, and comparing the abundance of miR-374a in the sample with a reference abundance of miR-374a, wherein a reduced abundance of miR-374a in the sample compared with the reference abundance of miR-374a is indicative of the distressed neonate being at risk of having or developing HIE. Risk of severe HIE can be determined by assaying a biological sample from the distressed neonate identified as being at risk of HIE for an abundance of a plurality of metabolites including succinate, glycerol, acetone and 3-hydroxybutyrate, providing the sum of glycerol and succinate abundance and the sum of acetone and 3-hydroxybutyrate; and correlating the sums with risk of severe HIE.
    • 用于筛选患有或发展HIE风险的不良新生儿的方法包括以下步骤:测定从苦闷的新生儿,新生儿的母亲或从脐带或胎盘获得的生物样品,以获得丰富的miR-374a 样品,并将样品中miR-374a的丰度与miR-374a的参考丰度进行比较,其中与miR-374a的参考丰度相比,样品中miR-374a的丰度降低,表示不良新生儿为 有发生或发展HIE的风险。 严重HIE的风险可以通过测定来自被认定为具有HIE风险的危重新生儿的生物样品来确定大量多种代谢物,包括琥珀酸盐,甘油,丙酮和3-羟基丁酸盐,提供甘油和琥珀酸盐丰度的总和 丙酮和3-羟基丁酸的总和; 并将这些总和与严重HIE的风险相关联。